Internet for Pharmaceutical and Biotech Communities
| Newsletter | Post Jobs | Advertising |
 
 

 

  

Pharm/Biotech Resources

Outsourcing Guide

Cont. Education

Software/Reports

Training Courses

Web Seminars

Jobs

Buyer's Guide

Home Page

Pharm Patents /
Licensing

Pharm News

Federal Register

Pharm Stocks

FDA Links

FDA Warning Letters

FDA Doc/cGMP

Pharm/Biotech Events

Consultants

Advertiser Info

Newsletter Subscription

Web Links

Suggestions

Site Map
 

 
   

 

  FDA Links  

Recent FDA Links
 

 New! Pharmaceutical Operation Software
 New! Free Pharm/Biotech Magazine Subscription

 
New!
 Pharmaceutical Business Intelligence Studies
 New! 
Pharm/Biotech Jobs
 New! Executive MBA in Pharmaceutical Management

 New! 
Pharmaceutical/Biotech Outsourcing Companies
 New!
 Pharm/Biotech Training Courses

 New! George Washington University's Healthcare MBA
 New! PharmCast Research Store
 New! Pharm/Biotech Web Seminars

 

  1. FDA Drug Safety Communication: Ongoing safety review of oral bisphosphonates and atypical subtrochanteric femur fractures (3/10/2010)
     
  2. FDA Approves Botox to Treat Spasticity in Flexor Muscles of the Elbow, Wrist and Fingers (3/10/2010)
     
  3. BPCA/Pediatric Exclusivity Statistics: Pediatric Exclusivity Statistics (updated 3/10/2010)
     
  4. Drugs@FDA Download File (updated 3/10/2010)
     
  1. Realignment in the Office of New Drugs (3/9/2010)
     
  1. Guidance for Industry:  S9 Nonclinical Evaluation for Anticancer Pharmaceuticals (PDF - 170 KB) (3/5/2010)
     
  2. Office of Nonprescription Products Consumer Update: Hydroquinone Studies Under The National Toxicology Program (NTP) (3/5/2010)
     
  1. FDA Approves Name Change for Heartburn Drug Kapidex (3/4/2010)
     
  2. Follow-up letters to 6 companies marketing unapproved narcotics containing morphine sulfate (3/4/2010)
     
  3. Manual of Policies and Procedures (CDER MaPP) 7400.11 Management of the PTCC Nonclinical Biologics Subcommittee (PDF - 54 KB) (3/4/2010)
     
  4. Workshops, Meetings & Conferences (Biologics) DIA/FDA CDER/CBER Computational Science Annual Meeting (Posted: 3/4/2010)
     
  5. First-Time Generic Drug Approvals for February 2010 (3/4/2010)
     
  6. First-Time Generic Drug Approvals for January 2010 (3/4/2010)
     
  7. Drugs@FDA Download File (updated 3/4/2010)
     
  1. FDA Approves First Generic Tamsulosin to Treat Enlarged Prostate Gland (3/3/2010)
     
  1. Guidance for Industry: Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications (PDF - 406KB) (Posted: 3/2/2010)
     
  2. Influenza Virus Vaccine for the 2010-2011 Season (Posted: 3/2/2010)
     
  3. Drug Shortages: Current Drug Shortages: Cerezyme (imiglucerase) Injection (updated 3/2/2010)
     
  1. Approved Risk Evaluation and Mitigation Strategies (REMS) (updated 3/1/2010)
     
  2. Drug Shortages: Current Drug Shortages: Propofol Injection (updated 3/1/2010)
     
  1. 2009 Biological New Drug Application (NDA) and Abbreviated New Drug Application (ANDA) Approvals (Updated: 2/26/2010)
     
  2. 2009 Biological License Application Supplement Noteworthy Approvals (Updated: 2/26/2010)
     
  3. 2010 Biological Device Application Approvals (Updated: 2/26/2010)
     
  4. Guidance for Industry: Non-Inferiority Clinical Trials (PDF - 565 KB) (updated 2/26/2010):
     
  5. FDA and PAT for Pharma Manufacturing: FDA-Partnering with Industry; a joint FDA/URI College of Pharmacy conference, Bethesda, Maryland, Hyatt Regency Bethesda, May 11-12, 2010. Meeting information and registration (2/26/2010)
     
  1. FDA Expands Commitment to Patients with Rare Diseases (2/25/2010)
     
  2. Guidance for Industry (updated 2/25/2010):
    1. Adaptive Design Clinical Trials for Drugs and Biologics (PDF - 424 KB)
    2. Submission of Documentation in Applications for Parametric Release of Human and Veterinary Drug Products Terminally Sterilized by Moist Heat Processes (PDF - 69 KB)
    3. Individual Bioequivalence Guidances Newly Added Recommendations
       
  3. Drug Shortages: Current Drug Shortages: Ephedrine Injection (2/25/2010)
     
  4. Drug Shortages: Resolved Drug Shortages: Erythromycin Ophthalmic Ointment (2/25/2010)
     

February 24, 2010

  1. Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies (updated 2/24/2010)
     
  1. FDA Drug Safety Communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms (2/23/2010)
     
  2. Paragraph IV Patent Certifications  (updated 2/23/2010)
     

February 22, 2010

  1. Drug Safety Oversight Board Meeting, Public Summary, January 21, 2010 (2/22/2010)
     
  2. FDA Drug Safety Communication: Ongoing review of Avandia (rosiglitazone) and cardiovascular safety (2/22/2010)
     
  3. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations (2/22/2010)
     
  4. Orange Book: January 2010: Additions and Deletions to the Drug Product List (PDF - 121KB) (2/22/2010)
     
  5. Orange Book: Current Cumulative Supplement (PDF - 333KB) (2/22/2010)
     
  6. Drug Shortages: Current Drug Shortages: Acyclovir Tablets and Capsules (updated 2/22/2010)
     
  7. Drug Shortages: Resolved Drug Shortages: Indocin I. V. (indomethacin for injection) (2/22/2010)
     
  1. MedWatch Alert - Exjade (deferasirox): Boxed Warning (2/19/2010)
     
  2. Orange Book Annual 30th Edition (PDF - 16944KB) (2/19/2010)
     

February 18, 2010

  1. Questions and Answers: New Safety Requirements for Long-Acting Asthma Medications called Long-Acting Beta Agonists (LABAs) (2/18/2010)
     
  2. FDA Drug Safety Communication: New safety requirements for Long-Acting Inhaled Asthma Medications called Long-Acting Beta-Agonists (LABAs) (2/18/2010)
     
  3. Orange Book FR Safety or Effectiveness Determinations List (PDF) (PDF - 134KB) (2/18/2010)
     
  4. Drug Shortages: Current Drug Shortages: Propofol Injection (updated 2/18/2010)
     
  5. Drug Shortages: Current Drug Shortages: Technetium Tc99m Generators (updated 2/18/2010)
     
  1. 2010 Meeting Materials, Vaccines and Related Biological Products Advisory Committee (Draft Agenda, Member Roster, Posted: 2/17/2010)
     
  2. FDA Drug Safety Communication: Product Confusion with Maalox Total Relief and Maalox Liquid Products (2/17/2010)
     
  3. Medication Guides (updated 2/17/2010)
     
  4. Drugs@FDA Download File (updated 2/17/2010)
     
  5. Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies (updated 2/17/2010)
     
  1. The 13th US-Japan Cellular and Gene Therapy Conference on Systems Biology in Cell Cycle Regulation (Posted: 2/16/2010)
     
  2. FDA Drug Safety Communication: Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp (2/16/2010)
     
  3. Drug Shortages: Current Drug Shortages: Heparin Sodium Large Volume Premixed Infusion Solutions (2/16/2010)
     
  4. Drug Shortages: Current Drug Shortages: Technetium Tc99m Generators (updated 2/16/2010)
     

February 12, 2010

  1. Guidance for Industry:  Individual Product Bioequivalence Recommendations (updated 2/12/2010)
     
  2. Paragraph IV Patent Certifications (updated 2/12/2010)
     
  1. Bioresearch Monitoring Information System Database (updated 2/10/2010)
     
  2. Drugs@FDA Download File (updated 2/10/2010)
     
  1. Questions and Answers for Healthcare Professionals: CRESTOR and the JUPITER Trial (2/8/2010)
     

February 5, 2010

  1. FDA Drug Safety Communication: Risk of Progressive Multifocal Leukoencephalopathy (PML) with the use of Tysabri (natalizumab) (2/5/2010)
     
  2. Drug Shortages: Resolved Drug Shortages: Tamiflu (oseltamivir phosphate) powder, for oral suspension, 12mg/ml (updated 2/5/2010)
     
  3. Guidance for Industry: Contents of a Complete Submission for the Evaluation of Proprietary Names (PDF - 306 KB) (updated 2/5/2010)
     
  1. Biologic Product Shortages (Updated PedvaxHIB & Comvax information; Updated: 2/4/2010)
     
  2. BPCA/Pediatric Exclusivity Statistics (updated 2/4/2010)
    1. Pediatric Exclusivity Statistics
    2. Written Requests Issued
       
  3. Drugs@FDA Download File (updated 2/4/2010)
     

February 3, 2010

  1. FDA approves Xiaflex (collagenase clostridium histolyticum) for debilitating hand condition (2/3/2010)
     
  2. Complete List of Substantially Equivalent 510(k) Device Applications (PDF - 796KB) (Updated: 2/3/2010)
     
  3. Complete List of Currently Approved NDA and ANDA Application Submissions (PDF - 171KB) (Updated: 2/3/2010)
     
  4. Complete List of Currently Approved Premarket Approvals (PMAs) (PDF - 36KB) (Updated: 2/3/2010)
     
  5. First-Time Generics - December 2009 (Updated: 2/3/2010)
     
  1. Postmarket Requirements and Commitments Database (updated 2/2/2010)
     
  2. Drug Shortages: Current Drug Shortages: Acyclovir Tablets and Capsules (updated 2/2/2010)
     
  1. MedWatch Alert - Zyprexa (olanzapine): Use in Adolescents (2/1/2010)
     
  1. FDA issued a Drug Safety Communication: Serious liver disorder associated with the use of Videx/Videx EC (didanosine) (1/29/2010)
     

January 28, 2010

  1. Initiatives (Center for Drug Evaluation and Research) (1/28/2010)
     
  1. Cord Blood Licensure: A Workshop (Posted: 1/27/2010)
     
  2. Drug Shortages: Resolved Drug Shortages: Morphine Sulfate Oral Solution (updated 1/27/2010)
     
  1. Guidance for Industry (updated 1/26/2010):
    1. Assessment of Abuse Potential of Drugs (PDF - 138 KB)
    2. The Use of Mechanical Calibration of Dissolution Apparatus 1 and 2 – Current Good Manufacturing Practice (CGMP)(PDF - 38 KB)
       
  2. MedWatch Alert - Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment (1/26/2010)
     
  3. Blood Establishment Computer Software: Understanding What to Include in a 510(k) Submission; Public Workshop (Transcripts Posted, Updated: 1/26/2010)
     
  4. List of Authorized Generic Drugs (updated 1/26/2010)
     
  5. Drug Shortages: Current Drug Shortages: Erythromycin Ophthalmic Ointment (updated 1/26/2010)
     
  1. FDA approves Ampyra (dalfampridine) extended release tablets to improve walking in adults with multiple sclerosis (1/25/2010)
     
  1. UPDATED Public Health Alert: Counterfeit Alli containing sibutramine (1/22/2010)
     
  2. Public Workshop: Emerging Arboviruses: Evaluating the Threat to Transfusion and Transplantation Safety (Transcripts Added, Updated: 1/22/2010)
     

January 21, 2010

  1. Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies (updated 1/21/2010)
     
  2. Drugs@FDA Download File (updated 1/21/2010)
     
  1. Guidance for Industry: M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals (PDF - 295 KB) (1/20/2010)
     
  2. November 18-19, 2009: Vaccines and Related Biological Products Advisory Committee Briefing Documents Presentations and Transcripts Posted (Updated: 1/20/2010)
     
  3. Drug Shortages: Current Drug Shortages: Octreoscan (Kit for the Preparation of Indium In 111 Pentetreotide) (1/20/2010)
     
  4. Drug Shortages: Resolved Drug Shortage: Mustargen (mechlorethamine HCl) injection (1/20/2010)
     
  5. Technetium-99m Radiopharmaceutical Product Shortage (Updated: 1/20/2010)
     

   

Hit Counter

     
[ Outsourcing Guide ] [ Cont. Education ] [ Software/Reports ] [ Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ]

[ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ]
[ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ]
[ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ]
[ Site Map ]